Antidote Technologies

Miami, FL, USA (as a subsidiary of 83Bar), with key offices in New York, NY, USA and London, UK  All United States companies → — Founded 2010
Biotech / Drug Discovery Patient Engagement Platform
Cardiology Neurology Oncology
Drug Discovery & Research
Acquired (Operating Subsidiary) — $57.2M

Products

Antidote.me
Antidote Technologies, Inc.
Drug Discovery & Research
Antidote.me leverages AI to connect patients and researchers to relevant clinical trials, addressing the problem of participant recruitment delays in medical research and accelerating the path to medical breakthroughs.

See all 1 product →

About Antidote Technologies

Antidote Technologies is a digital health company dedicated to accelerating medical research by transforming how patients and researchers connect. The company addresses the critical challenge of clinical trial recruitment, where a significant percentage of studies are delayed or closed due to insufficient participants. Antidote’s core offering, Antidote Match™, is an AI-powered clinical trial matching engine that leverages structured eligibility criteria and proprietary algorithms to efficiently connect patients with suitable clinical trials. [2, 3, 11, 13, 14, 17, 20, 21, 22, 23, 24, 25, 27, 28]

For physicians and researchers, Antidote provides a precision recruitment solution that streamlines the identification and engagement of eligible and diverse patient populations. [2, 3, 11, 16, 22, 23, 26, 27] By integrating data-driven technologies, digital expertise, and a vast partner network, Antidote aims to reduce site burden, optimize patient engagement, and provide valuable insights into the recruitment funnel. [2, 3, 11, 14, 18, 21, 22, 23, 26, 27] Their platform supports a patient-centric approach, making it easier for individuals to find and understand trial opportunities, ultimately helping to bring new treatments to patients faster. [3, 11, 17, 19, 20, 21, 23, 25]

Focus Areas

Clinical trial matching patient recruitment patient engagement medical research precision recruitment digital health AI in healthcare

Business Intelligence

Key InvestorsAmadeus Capital Partners, Octopus Ventures, Smedvig Capital, Merck Global Health Innovation Fund, LBO France
PartnershipsSEQSTER (July 2024), XpertPatient (February 2026), Sirona Dx (October 2023), OneStudyTeam
AcquisitionsAcquired by 83Bar (March 1, 2025)
TechnologyAI-powered clinical trial matching engine (Antidote Match™), structured eligibility criteria, proprietary algorithms, machine learning, data-driven technologies, digital expertise, EHR-matching capabilities

What Physicians Need to Know

Specialization: Clinical Trial Patient Recruitment
Antidote Technologies is a digital health company dedicated to accelerating medical research by transforming how patients and researchers connect. They specialize in precision recruitment to match the right patients with the right clinical trials.
Core Product: Antidote Matchu2122
Their signature offering, Antidote Matchu2122, is a clinical trial matching engine that utilizes structured eligibility criteria, medical ontologies, and proprietary algorithms to explore a patient's eligibility for various trials.
Data-Driven & AI-Powered Matching
Antidote integrates data-driven technologies and digital expertise to identify suitable participants, ensuring high-quality patient engagement and efficient matching.
Extensive Partner Network
Antidote powers clinical trial search for over 250 patient advocacy groups, health websites, and research organizations, expanding its reach to connect patients with research.
Optimizing Clinical Trial Design
They offer Antidote INSIGHTS, a data product providing aggregated, de-identified data on patient eligibility criteria and demographics to help optimize clinical trial design.
Physician Tip

For physicians, Antidote Technologies offers a valuable tool to streamline the process of finding relevant clinical trials for your patients. By leveraging Antidote Matchu2122, you can quickly identify research opportunities that align with your patients' conditions and eligibility criteria, potentially offering new treatment avenues and contributing to medical advancements. This can save significant time compared to manual searches and enhance patient care by connecting them with cutting-edge research. The platform's focus on precision recruitment and data integration means you can trust the quality of the matches. Consider integrating Antidote's tools into your patient referral workflows to efficiently explore clinical trial options.

Antidote's technology is designed for integration within the broader clinical research ecosystem. Their Antidote Matchu2122 platform integrates with numerous patient advocacy groups and health portals. They have established partnerships with companies like OneStudyTeam and SEQSTER to enhance patient identification, streamline site workflows, and facilitate the delivery of patient demographic information and referrals directly into clinical trial management platforms. This allows for a more connected and efficient patient referral and enrollment experience, potentially incorporating data points like lab results when integrated with other data sources.

Products by Antidote Technologies

1 product in the directory

Antidote.me
Antidote Technologies, Inc.
Drug Discovery & Research
Antidote.me leverages AI to connect patients and researchers to relevant clinical trials, addressing the problem of participant recruitment delays in medical research and accelerating the path to medical breakthroughs.

Reviews & Opinions

No web reviews on file yet for Antidote Technologies. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Antidote Technologies.

Loading videos...

Videos load interactively. If none appear, search YouTube for Antidote Technologies →

View all on YouTube

Press & Coverage

Clinical Trials Arena
Antidote Technologies and SEQSTER partner to improve patient enrolment for trials
Antidote Technologies and SEQSTER have partnered to enhance patient identification and enrollment in clinical trials, aiming to reduce timelines for pharmaceutical and life science companies. This collaboration integrates SEQSTER's data integration capabilities with Antidote's patient recruitment and support services.
2024-07
PRWeb
Antidote and Melanoma Research Alliance join forces to enhance clinical trial search for people impacted by melanoma
Antidote Technologies and the Melanoma Research Alliance (MRA) have strengthened their collaboration to improve the Clinical Trial Navigator, MRA's clinical trial finder powered by Antidote Matchu2122. The partnership aims to facilitate more accurate matches to appropriate clinical trials for individuals affected by melanoma.
2024-03
Antidote Technologies Press Release
Antidote Raises $23 Million to Scale Digital Patient Engagement Services
Antidote Technologies announced it closed $23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, with participation from existing investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures.
2021-06
PRWeb
Antidote Technologies' Report on Survey of 4,000 Patients Reveals How to Increase Diversity in Clinical Research
Antidote Technologies released findings from a survey of 4,000 patients and caregivers on their attitudes toward clinical research, highlighting insights into reducing barriers for underrepresented populations. The survey suggests tailoring study design and outreach to specific populations can increase participation and lead to more effective drugs.
2020-01
PatientPoint
PatientPoint and Antidote Team Up to Drive Clinical Trial Recruitment at the Point of Care
PatientPoint and Antidote Technologies partnered to enhance clinical trial recruitment by directing patients and providers to Antidote's digital clinical trial search tool in over 7,300 primary care and subspecialty practices nationwide. This collaboration aims to bridge the gap between medical research and patients.
2019-02
Emerj Artificial Intelligence Research
AI and Machine Learning for Clinical Trials - Examining 3 Current Applications
Antidote is highlighted for its use of machine learning to connect patients with medical research studies through its clinical trial matching platform. The company's algorithms are trained on patient eligibility criteria to search thousands of open trials.
2018-09
Becker's Hospital Review
Antidote raises $11M in funding round led by Merck Global Health Innovation Fund
Antidote Technologies secured an $11 million funding round led by Merck Global Health Innovation Fund, with participation from Smedvig Capital and Octopus Ventures. This investment aims to accelerate the development of its trial matching platform, including precision medicine and EHR-matching capabilities.
2017-09
Multiple Sclerosis Association of America (MSAA)
Multiple Sclerosis Association of America and Antidote Technologies Team Up to Increase Awareness of Clinical Trials
The Multiple Sclerosis Association of America (MSAA) and Antidote Technologies announced a partnership to increase awareness of MS clinical trials. Antidote Match, a clinical trial search tool, is now available on MSAA's website to help individuals find relevant trials.
2017-01

Frequently Asked Questions

Antidote Technologies provides Antidote Matchu2122, an AI-powered clinical trial matching engine designed to connect patients with suitable research opportunities. They also offer digital patient engagement solutions and data insights products to assist researchers in designing more patient-centric clinical trials.
Antidote Technologies places a high priority on data privacy and security, as evidenced by achieving exceptional scores in cybersecurity risk assessments, including a 100% score in privacy. They are committed to managing and governing data in strict accordance with applicable regulations and industry best practices.
Antidote Technologies employs a flexible pricing strategy, including a 'calibration model' where an initial flat fee helps determine the per-patient recruitment cost. This can then transition into a pay-for-performance model, which aims to optimize costs and potentially lead to savings for trial sponsors.
Antidote Technologies focuses on supporting research sites by delivering high-quality patient referrals and integrating solutions to reduce administrative burden. Their partnerships also contribute to streamlining workflows for healthcare professionals involved in clinical trials.
Antidote Technologies boasts an extensive global network, partnering with hundreds of patient advocacy groups, health websites, and research foundations. Key collaborations include partnerships with SEQSTER and OneStudyTeam, aimed at enhancing patient identification and streamlining clinical trial enrollment processes.
Antidote Technologies has demonstrated strong financial growth, with a 66% increase in annual revenue in 2020. The company secured $23.2 million in funding in 2021 from notable investors such as LBO France and Merck Global Health Innovation Fund, indicating robust investor confidence and a positive outlook for continued expansion.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.